These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6322367)

  • 21. The melanocortin 4 receptor mediates leptin stimulation of luteinizing hormone and prolactin surges in steroid-primed ovariectomized rats.
    Watanobe H; Schiöth HB; Wikberg JE; Suda T
    Biochem Biophys Res Commun; 1999 Apr; 257(3):860-4. PubMed ID: 10208874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey.
    Gilbeau PM; Almirez RG; Holaday JW; Smith CG
    J Clin Endocrinol Metab; 1985 Feb; 60(2):299-305. PubMed ID: 2981242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed sexual maturation during prepubertal cannabinoid treatment: importance of the timing of treatment.
    Field E; Tyrey L
    J Pharmacol Exp Ther; 1990 Jul; 254(1):171-5. PubMed ID: 2164090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influences of GnRH, oxytocin and vasoactive intestinal peptide on LH and PRL secretion by porcine pituitary cells in vitro.
    Bogacka I; Siawrys G; Okrasa S; Kaminski T; Przala J
    J Physiol Pharmacol; 2002 Sep; 53(3):439-51. PubMed ID: 12369740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. delta 9-Tetrahydrocannabinol: a potent inhibitor of episodic luteinizing hormone secretion.
    Tyrey L
    J Pharmacol Exp Ther; 1980 May; 213(2):306-8. PubMed ID: 6245207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catecholamine mechanisms in the feedback effects of estradiol benzoate on the release of LH and prolactin.
    Tobias H; Carr LA; Voogt JL
    Proc Soc Exp Biol Med; 1983 Nov; 174(2):284-90. PubMed ID: 6356136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delta-9-tetrahydrocannabinol: its effect on hypothalamo-pituitary system in male rats.
    Chakravarty I; Sheth PR; Sheth AR; Ghosh JJ
    Arch Androl; 1982 Feb; 8(1):25-7. PubMed ID: 6279040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of opiate antagonists on serotonin turnover and on luteinizing hormone and prolactin secretion in estrogen- or morphine-treated rats.
    Johnson MD; Crowley WR
    Neuroendocrinology; 1984 Apr; 38(4):322-7. PubMed ID: 6328344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of delta 9-tetrahydrocannabinol (THC) with hypothalamic neurotransmitters controlling luteinizing hormone and prolactin release.
    Steger RW; DePaolo L; Asch RH; Silverman AY
    Neuroendocrinology; 1983 Nov; 37(5):361-70. PubMed ID: 6139760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperprolactinemia decreases the luteinizing hormone-releasing hormone concentration in pituitary portal plasma: a possible role for beta-endorphin as a mediator.
    Sarkar DK; Yen SS
    Endocrinology; 1985 May; 116(5):2080-4. PubMed ID: 3157564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo and in vitro studies on the opioidergic control of the secretion of gonadotrophin-releasing hormone and luteinizing hormone in sexually immature and adult male rats.
    Leposavic G; Cover PO; Buckingham JC
    Neuroendocrinology; 1991 Jun; 53(6):579-88. PubMed ID: 1652110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat.
    Murphy LL; Steger RW; Smith MS; Bartke A
    Neuroendocrinology; 1990 Oct; 52(4):316-21. PubMed ID: 1979838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal organization of the brain opioid systems controlling prolactin and luteinizing hormone secretion.
    Limonta P; Dondi D; Maggi R; Martini L; Piva F
    Endocrinology; 1989 Feb; 124(2):681-6. PubMed ID: 2912695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid-glutamate-nitric oxide connection in the regulation of luteinizing hormone secretion in the rat.
    Bhat GK; Mahesh VB; Ping L; Chorich L; Wiedmeier VT; Brann DW
    Endocrinology; 1998 Mar; 139(3):955-60. PubMed ID: 9492025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of prolactin secretion by adrenal steroids in oestrogen-treated ovariectomized rats: participation of endogenous opioid peptides.
    Carón RW; Salicioni AM; Deis RP
    Neuropharmacology; 1997 Oct; 36(10):1433-8. PubMed ID: 9423931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of delta-9-tetrahydrocannabinol on the hypothalamic-pituitary control of luteinizing hormone and follicle-stimulating hormone secretion in adult male rats.
    Wenger T; Rettori V; Snyder GD; Dalterio S; McCann SM
    Neuroendocrinology; 1987 Dec; 46(6):488-93. PubMed ID: 2827048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential in vitro stimulation by naloxone and K+ of luteinizing hormone-releasing hormone and catecholamine release from the hypothalami of intact and castrated rats.
    Kalra PS; Crowley WR; Kalra SP
    Endocrinology; 1987 Jan; 120(1):178-85. PubMed ID: 3536452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of serotonin depletion by p-chlorophenylalanine on serum prolactin levels in estrogen-treated ovariectomized rats: insights concerning the serotoninergic, dopaminergic and opioid systems.
    Mallmann ES; Ribeiro MF; Spritzer PM
    Horm Metab Res; 2001 Jun; 33(6):337-42. PubMed ID: 11456281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fos expression by naloxone in LHRH neurons of the mediobasal hypothalamus and effects of pentobarbital sodium in the proestrous rat.
    Funabashi T; Jinnai K; Kimura F
    J Neuroendocrinol; 1997 Feb; 9(2):87-92. PubMed ID: 9041360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Participation of both adrenergic and opioidergic systems in the negative feedback of adrenal progesterone on LH secretion.
    Salicioni AM; Carón RW; Deis RP
    Eur J Pharmacol; 1997 Aug; 332(3):283-7. PubMed ID: 9300262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.